Safrel Pharmaceuticals LLC

Warning letter issued August 7, 2026 · Dayton, New Jersey

Inspection: Jan 13 – Jan 30, 2026
Pages: 5
FEI number: 3042030663

In short: On August 7, 2026, FDA sent a warning letter to Safrel Pharmaceuticals LLC in Dayton, New Jersey (FEI 3042030663).

Inside this warning letter

The full warning letter

Every page of the warning letter, exactly as written.

Get the full warning letter

This inspection in context

The firm

Safrel Pharmaceuticals LLC history

All 2 documents on file for this site, in date order, with what was cited at each inspection.

Questions about this warning letter

When was Safrel Pharmaceuticals LLC inspected by FDA?

The inspection ran Jan 13 – Jan 30, 2026, and the Warning letter is dated August 7, 2026.

How do I get the full Warning letter for Safrel Pharmaceuticals LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.